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ABSTRACT 
 
 
This paper examines the value relevance of R&D reporting among public listed 
companies in Malaysia for the years 2000 and 2001, subsequent to the introduction of 
FRS 109, Accounting for Research and Development (formerly known as MASB 4). FRS 
109 states that a firm should expense its research costs and could capitalize the 
development cost if the latter is expected to bring future benefits. Otherwise, the 
development expenditure is to be expensed. Test results based on Ohlson’s (1995) 
valuation model shows that for capitalizers, the amount of R&D expenditure, either 
expensed or capitalized, influences the stock prices positively. As for the expensers, even 
though the amount expensed influences stock prices, this relationship is driven by 
outliers; when we dropped the outliers, the result is no longer significant. These results 
indicate that R&D activities of capitalizers are expected to bring future benefits and 
consequently lead to higher prices while the R&D activities of expensers are more 
difficult to evaluate given a small sample size and the presence of outliers. 
 
 
